Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer.

@article{Baumgart2011UrogenitalDI,
  title={Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer.},
  author={Juliane Baumgart and Kerstin A Nilsson and Anneli Stavreus-Evers and Kristiina Kask and Kenneth K Villman and Henrik Lindman and Theodora Kunovac Kallak and Inger Sundstr{\"o}m-Poromaa},
  journal={American journal of obstetrics and gynecology},
  year={2011},
  volume={204 1},
  pages={26.e1-7}
}
OBJECTIVE To investigate the prevalence of urogenital symptoms and vaginal atrophy in postmenopausal breast cancer patients on adjuvant endocrine therapy. STUDY DESIGN A population-based, cross-sectional study on postmenopausal breast cancer patients on adjuvant endocrine treatment and age-matched control subjects. Vaginal atrophy was assessed by gynecologic examination and atrophy-related symptoms by validated questionnaires. RESULTS In all, 57.6% of aromatase inhibitor-treated and 32.4… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS